Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,538 | -6,078 | -2,474 | -11,854 | 20 |
| Depreciation Amortization | 893 | 220 | 108 | 509 | 297 |
| Accounts receivable | N/A | N/A | N/A | N/A | 68 |
| Accounts payable and accrued liabilities | -3 | 386 | 3 | N/A | -41 |
| Other Working Capital | 72 | 419 | 12 | 516 | 134 |
| Other Operating Activity | 2,149 | 73 | 46 | 540 | 0 |
| Operating Cash Flow | $-7,427 | $-4,980 | $-2,305 | $-10,289 | $478 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -99 | -99 | -52 | -125 | -4 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -134 |
| Investing Cash Flow | $-99 | $-99 | $-52 | $-125 | $-138 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,602 | 5,602 | 5,000 | N/A | N/A |
| Debt Repayment | -112 | -80 | -48 | N/A | N/A |
| Common Stock Issued | 23 | 84 | 15 | N/A | 48 |
| Other Financing Activity | -24 | -23 | 0 | -137 | -17 |
| Financing Cash Flow | $5,489 | $5,583 | $4,967 | $-137 | $32 |
| Beginning Cash Position | 3,558 | 3,558 | 3,558 | 14,109 | 1,198 |
| End Cash Position | 1,521 | 4,062 | 6,168 | 3,558 | 1,569 |
| Net Cash Flow | $-2,037 | $504 | $2,610 | $-10,551 | $371 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,427 | -4,980 | -2,305 | -10,289 | 478 |
| Capital Expenditure | -99 | -99 | -52 | N/A | -4 |
| Free Cash Flow | -7,526 | -5,079 | -2,357 | -10,289 | 474 |